Defeating Anthrax withIts Own Weapons?
Vaccine candidate? Researchers synthesize oligosaccharide from anthraxpathogen
The first step in the development of a vaccine is the search for a suitable antigen. As in most bacteria, Bacillus anthracis has specific oligosaccharides on the surface of its spores which probably play an important role in the interaction between the bacteria and the infected organism. The structure of such an oligosaccharide was determined last year. The molecule consists of four sugar units. Of particular interest is one of the terminal sugar units, called anthrose, which clearly appears exclusively on the surface ofanthrax spores.
Peter Seeberger and Daniel Werz at the ETH in Zürich have now generated this tetrasaccharide by a total synthesis for the first time. At the core of their method is a new, particularly effective synthetic pathway for the anthrose unit. At the same time, the researchers also attached a type of molecular hook to the syntheticmolecule. The hook can subsequently be coupled to a transport protein, which is necessary for successful immunization. The overall synthetic pathway is so flexible that different variations of the sugarmolecule are easily accessible. "We are currently carrying out immunological studies with the tetrasaccharide," says Seeberger, "at the same time, we are preparing a number of derivatives of the sugar in order to highlight their potential as highly specific anthrax vaccines."
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.